Drugs / Renal clairance study
Renal clairance study
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06846034 | Feb 2025 → Sep 2026 expected | diabetic kidney disease, type 2 diabetes mellitus | Poitiers University Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Renal clairance study | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06846034 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic agent used to measure effective renal plasma flow (ERPF)” NCT06846034 ↗ |